Differing effects when using phenylephrine and norepinephrine to augment cerebral blood flow after traumatic brain

Stuart H Friess1, Benjamin Bruins, Todd J Kilbaugh

  • 11 Department of Pediatrics, Washington University in St. Louis School of Medicine , St. Louis, Missouri.

Insights

Phenylephrine (PE) improved outcomes more than norepinephrine (NE) in swine models of traumatic brain injury (TBI). PE reduced cell injury and metabolic crisis, suggesting it may be a better vasopressor for TBI management.

Area of Science:

  • Neuroscience
  • Trauma Surgery
  • Pediatric Critical Care

Background:

  • Low cerebral blood flow (CBF) after traumatic brain injury (TBI) in children is linked to poor outcomes.
  • Cerebral perfusion pressure (CPP) support is used to treat cerebral hypoperfusion, but vasopressor efficacy is unclear.

Purpose of the Study:

  • To compare the efficacy of phenylephrine (PE) and norepinephrine (NE) in supporting CPP and improving outcomes after TBI in a pediatric swine model.

Main Methods:

  • Sixteen 4-week-old swine experienced nonimpact inertial TBI.
  • Intraparenchymal monitors measured ICP, CBF, PbtO2, and microdialysis.
  • Animals received PE or NE infusions to maintain CPP > 70 mm Hg for 5 hours post-injury.

Main Results:

  • Both PE and NE increased CBF similarly, with no difference in ICP.
  • NE resulted in higher PbtO2 than PE, but PE led to a greater reduction in metabolic crisis (lactate/pyruvate ratio).
  • PE-supported CPP augmentation showed significantly smaller cell injury volumes compared to NE.

Conclusions:

  • Despite similar CBF increases, NE resulted in greater hypoxic-ischemic injury than PE.
  • PE may be a more effective vasopressor for CPP augmentation in pediatric TBI compared to NE.
  • Further clinical trials are needed to compare vasopressor effectiveness in TBI management.

Keywords:
CBFCPPNEPETBI